January 26, 2023 08:08 AM ESTUpdated February 7, 09:30 AM

#JPM23: What's re­al­ly dri­ving the cost of health­care and drugs in 2023?

Drew Armstrong

Executive Editor

Ex­ec­u­tive Ed­i­tor Drew Arm­strong spoke with PhRMA CEO Steve Ubl, Em­sa­naRx CEO Greg Bak­er and ICER Pres­i­dent Steve Pear­son about how the de­bate over drug …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

New fund will pres­sure flail­ing biotechs, as in­vestor frus­tra­tion boils over

Ake­so shares new da­ta sug­gest­ing it can beat Keytru­da on sur­vival, wins Chi­na ap­proval

FDA chief Makary talks ex­pe­dit­ing drug ap­provals, RIFs and the abor­tion pill

Mer­ck KGaA clos­es in on Spring­Works deal at $3.5B price point

Ab­b­Vie com­mits $10B to ex­pand US foot­print with the threat of tar­iffs ahead

sponsored

AD­STI­LADRIN® (nad­o­fara­gene fi­rade­n­ovec-vncg) – A Grow­ing Body of Clin­i­cal Da­ta and Re­al-World Ev­i­dence

A service from the Financial Times